Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications
暂无分享,去创建一个
M. Díaz-Ricart | M. Palomo | M. Salas | Silvia Escribano-Serrat | J. Martinez-Sanchez | A. B. Moreno-Castaño | María Queralt Salas | Montserrat Rovira | Elena Guillén-Olmos | Sara Fernandez | Helena Ventosa-Capell | Lina Youssef | F. Crispi | Meritxell Nomdedeu | Blanca De Moner | Montserrat Rovira | Blanca de Moner
[1] C. Reinhardt,et al. Gut Microbiota and the Microvasculature. , 2023, Cold Spring Harbor perspectives in medicine.
[2] P. Póvoa,et al. Endothelial dysfunction triggers acute respiratory distress syndrome in patients with sepsis: a narrative review , 2023, Frontiers in Medicine.
[3] Ansuman T. Satpathy,et al. CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity , 2023, Journal for ImmunoTherapy of Cancer.
[4] J. Yugar-Toledo,et al. Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review , 2023, Frontiers in Cardiovascular Medicine.
[5] S. Ganguly,et al. From bench to bedside: the history and progress of CAR T cell therapy , 2023, Frontiers in Immunology.
[6] K. Stark,et al. Thromboinflammation in long COVID—the elusive key to postinfection sequelae? , 2023, Journal of Thrombosis and Haemostasis.
[7] V. Novakovic,et al. Damage to endothelial barriers and its contribution to long COVID , 2023, Angiogenesis.
[8] R. Liu,et al. A comprehensive analysis of coagulopathy during anti‐B cell maturation antigen chimeric antigen receptor‐T therapy in multiple myeloma, a retrospective study based on LEGEND‐2 , 2023, Hematological oncology.
[9] K. Stamatelopoulos,et al. Endothelial dysfunction and immunothrombosis in sepsis , 2023, Frontiers in Immunology.
[10] M. Díaz-Ricart,et al. Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis , 2023, Journal for ImmunoTherapy of Cancer.
[11] M. Brittan,et al. The role of the endothelium in severe acute respiratory syndrome coronavirus 2 infection and pathogenesis , 2023, Current opinion in physiology.
[12] N. Shah,et al. How I treat refractory CRS and ICANS after CAR T-cell therapy , 2023, Blood.
[13] H. Haybar,et al. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID‐19 patients: A systematic review and meta‐analysis , 2023, Reviews in medical virology.
[14] Jianmin Yang,et al. Hemophagocytic lymphohistiocytosis and disseminated intravascular coagulation are underestimated, but fatal adverse events in chimeric antigen receptor T-cell therapy , 2023, Haematologica.
[15] Keir J. Menzies,et al. Placental Mitochondrial Function and Dysfunction in Preeclampsia , 2023, International journal of molecular sciences.
[16] G. Kaplanski,et al. Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura? , 2023, Journal of clinical medicine.
[17] M. Díaz-Ricart,et al. Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro , 2023, Bone Marrow Transplantation.
[18] P. Jud,et al. Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases , 2022, Thrombosis and Haemostasis.
[19] M. Klein,et al. Early Vascular Aging in Obese Individuals with Low Cardiovascular Health , 2022, High Blood Pressure & Cardiovascular Prevention.
[20] P. Chiusolo,et al. Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells , 2022, British journal of haematology.
[21] M. Díaz-Ricart,et al. Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development , 2022, Frontiers in Immunology.
[22] Arthur S Slutsky,et al. Respiratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis , 2022, The Lancet Respiratory Medicine.
[23] J. Thachil,et al. Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations. , 2022, Seminars in thrombosis and hemostasis.
[24] M. Gorospe,et al. Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging , 2022, International journal of molecular sciences.
[25] Songying Zhang,et al. Trophoblast-Derived Extracellular Vesicles Promote Preeclampsia by Regulating Macrophage Polarization , 2022, Hypertension.
[26] Yan Zhao,et al. Inflammation in Preeclampsia: Genetic Biomarkers, Mechanisms, and Therapeutic Strategies , 2022, Frontiers in Immunology.
[27] P. Pedrazzoli,et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 , 2022, Bone Marrow Transplantation.
[28] M. Díaz-Ricart,et al. Complement Mediated Endothelial Damage in Thrombotic Microangiopathies , 2022, Frontiers in Medicine.
[29] L. Bullinger,et al. EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study , 2022, Frontiers in Immunology.
[30] F. Ní Áinle,et al. Preeclampsia and Venous Thromboembolism: Pathophysiology and Potential Therapy , 2022, Frontiers in Cardiovascular Medicine.
[31] Xiuhua Yang,et al. A Review of Roles of Uterine Artery Doppler in Pregnancy Complications , 2022, Frontiers in Medicine.
[32] A. Ramos,et al. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy , 2022, American Journal of Obstetrics and Gynecology.
[33] N. Freemantle,et al. Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data , 2021, Clinical nephrology.
[34] O. Oluwole,et al. Overview of approved CAR‐T therapies, ongoing clinical trials, and its impact on clinical practice , 2021, EJHaem.
[35] M. Perales,et al. Modified-EASIX predicts severe cytokine release syndrome and neurotoxicity after Chimeric Antigen Receptor (CAR) T cells. , 2021, Blood advances.
[36] Michael L. Wang,et al. CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. , 2021, Blood advances.
[37] E. Gratacós,et al. Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction , 2021, Scientific Reports.
[38] G. Nuovo,et al. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19 , 2021, Clinics in Dermatology.
[39] K. Meyer,et al. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells , 2021, Journal of virology.
[40] P. Richardson,et al. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes , 2021, Shock.
[41] P. Richardson,et al. Endothelial dysfunction and its critical role in COVID‐19‐associated coagulopathy: Defibrotide as an endothelium‐protective, targeted therapy , 2021, EJHaem.
[42] P. Richardson,et al. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? , 2021, Cardiovascular Drugs and Therapy.
[43] Lei Li,et al. Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation , 2021, Frontiers in Immunology.
[44] M. Sadelain,et al. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy , 2021, Nature Reviews Immunology.
[45] T. Welte,et al. Between inflammation and thrombosis: endothelial cells in COVID-19 , 2021, European Respiratory Journal.
[46] S. Chawla,et al. Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study. , 2021, The Lancet. Haematology.
[47] G. Ippolito,et al. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review , 2021, International journal of molecular sciences.
[48] M. Díaz-Ricart,et al. Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contender , 2021, Journal of thrombosis and haemostasis : JTH.
[49] N. Kröger,et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years , 2021, Bone Marrow Transplantation.
[50] P. Richardson,et al. COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies , 2021, British journal of haematology.
[51] E. Gratacós,et al. Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics , 2021, Scientific Reports.
[52] M. J. Al-Farabi,et al. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis , 2021, Microvascular Research.
[53] S. Rives,et al. Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy. , 2021, Blood advances.
[54] C. Turtle,et al. Cytokines in CAR T Cell–Associated Neurotoxicity , 2020, Frontiers in Immunology.
[55] A. García-Herrera,et al. Thrombotic microangiopathies assessment: mind the complement , 2020, Clinical kidney journal.
[56] G. Gutiérrez-García,et al. The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever , 2020, PloS one.
[57] Meera Sridharan,et al. Complement in Secondary Thrombotic Microangiopathy , 2020, Kidney International Reports.
[58] S. Oparil,et al. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.
[59] S. Karumanchi,et al. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders , 2020, American journal of obstetrics and gynecology.
[60] Kristen M. Tecson,et al. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. , 2020, Reviews in cardiovascular medicine.
[61] He Huang,et al. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy , 2020, Bone Marrow Transplantation.
[62] P. Libby,et al. COVID-19 is, in the end, an endothelial disease , 2020, European heart journal.
[63] V. Garovic,et al. Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia , 2020, Frontiers in Immunology.
[64] S. Nagashima,et al. Endothelial Dysfunction and Thrombosis in Patients With COVID-19—Brief Report , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[65] C. Weber,et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science , 2020, Cardiovascular research.
[66] S. Adkins,et al. Recognizing and Grading CAR T-Cell Toxicities: An Advanced Practitioner Perspective , 2020, Frontiers in Oncology.
[67] M. Díaz-Ricart,et al. Defibrotide inhibits donor leucocyte‐endothelial interactions and protects against acute graft‐versus‐host disease , 2020, Journal of cellular and molecular medicine.
[68] M. Díaz-Ricart,et al. Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease , 2020, Toxins.
[69] A. Anagnostopoulos,et al. A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity , 2020, International journal of molecular sciences.
[70] M. Arshad,et al. Cardiovascular Manifestations of COVID-19 , 2020, Current Cardiology Reviews.
[71] Axel Haverich,et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.
[72] R. McIntyre,et al. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection , 2020, Journal of the American College of Surgeons.
[73] G. Gutiérrez-García,et al. The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium , 2020, Bone Marrow Transplantation.
[74] N. Chao,et al. Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation , 2020, British journal of haematology.
[75] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[76] L. Appel,et al. The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis , 2020, medRxiv.
[77] K. Griendling,et al. The effects of sepsis on endothelium and clinical implications. , 2020, Cardiovascular research.
[78] S. Crawford,et al. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[79] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[80] L. G. Vu,et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.
[81] Brendon M. Baker,et al. Functional angiogenesis requires microenvironmental cues balancing endothelial cell migration and proliferation , 2019, bioRxiv.
[82] Junnian Zheng,et al. Coagulation Disorders after CAR T Cell Therapy: Analysis of 100 Patients with R/R Hematologic Malignancies. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[83] Moritz Reiterer,et al. Endothelial cells and organ function: applications and implications of understanding unique and reciprocal remodelling , 2019, The FEBS journal.
[84] E. Gratacós,et al. Complement Activation and Thrombotic Microangiopathies. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[85] E. Gratacós,et al. Distinctive patterns of placental lesions in pre‐eclampsia vs small‐for‐gestational age and their association with fetoplacental Doppler , 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[86] B. McDonald,et al. Platelets and Intravascular Immunity: Guardians of the Vascular Space During Bloodstream Infections and Sepsis , 2019, Front. Immunol..
[87] M. Díaz-Ricart,et al. Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide , 2019, Front. Immunol..
[88] José A Fernández,et al. Activated Protein C Ameliorates Chronic Graft-Versus-Host Disease by PAR1-dependent Biased Cell Signaling on T-cells. , 2019, Blood.
[89] M. Robin,et al. Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. , 2019, Blood advances.
[90] V. Srivastava,et al. Quantification of NETs formation in neutrophil and its correlation with the severity of sepsis and organ dysfunction. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[91] H. Hinson,et al. Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment , 2019, Current Treatment Options in Neurology.
[92] A. Khalil,et al. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function , 2019, International journal of molecular sciences.
[93] H. Hemker,et al. Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease , 2019, Clinical kidney journal.
[94] S. Rodríguez de Córdoba,et al. Secondary atypical hemolytic uremic syndromes in the era of complement blockade. , 2019, Kidney international.
[95] T. Guo,et al. Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy , 2019, Annals of Hematology.
[96] M. S. Sajib,et al. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology , 2019, Cells.
[97] M. Vervloet,et al. Most exposed: the endothelium in chronic kidney disease , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[98] S. Karumanchi,et al. Preeclampsia: Pathophysiology, Challenges, and Perspectives , 2019 .
[99] J. Kochenderfer,et al. Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management. , 2019, Blood reviews.
[100] M. Díaz-Ricart,et al. Endothelial Dysfunction in Hematopoietic Cell Transplantation , 2019, Clinical hematology international.
[101] A. Jain,et al. Association of pro‐ and anti‐inflammatory cytokines in preeclampsia , 2019, Journal of clinical laboratory analysis.
[102] Eric P. Schmidt,et al. The glycocalyx: a novel diagnostic and therapeutic target in sepsis , 2019, Critical Care.
[103] ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. , 2019, Obstetrics and gynecology.
[104] S. Rives,et al. Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions , 2018, Molecular therapy. Methods & clinical development.
[105] S. Burtey,et al. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease , 2018, Toxins.
[106] L. Magee,et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. , 2018, Hypertension.
[107] P. Richardson,et al. The use of defibrotide in blood and marrow transplantation. , 2018, Blood advances.
[108] S. Yuan,et al. A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation , 2018, Cardiovascular research.
[109] L. Deangelis,et al. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia. , 2018, Cancer discovery.
[110] M. Sadelain,et al. CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade , 2018, Nature Medicine.
[111] G. Gutiérrez-García,et al. Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation , 2018, Bone Marrow Transplantation.
[112] W. Gyselaers,et al. Oxidative stress and endothelial function in normal pregnancy versus pre-eclampsia, a combined longitudinal and case control study , 2018, BMC Pregnancy and Childbirth.
[113] E. Michos,et al. Adverse pregnancy outcomes and future maternal cardiovascular disease , 2018, Clinical cardiology.
[114] W. Stock,et al. Management of important adverse events associated with inotuzumab ozogamicin: expert panel review , 2018, Bone Marrow Transplantation.
[115] M. Wurfel,et al. Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells. , 2017, Cancer discovery.
[116] D. Miklos,et al. CNS Endothelial Cell Activation Emerges as a Driver of CAR T Cell-Associated Neurotoxicity. , 2017, Cancer discovery.
[117] Daniel Li,et al. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. , 2017, Blood.
[118] R. Storb,et al. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. , 2017, The Lancet. Haematology.
[119] S. Ye,et al. STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression , 2017, Oncogene.
[120] Ping Chen,et al. Simvastatin ameliorates graft-vs-host disease by regulating angiopoietin-1 and angiopoietin-2 in a murine model. , 2017, Leukemia research.
[121] E. Holler,et al. Pathophysiology of GvHD and Other HSCT-Related Major Complications , 2017, Front. Immunol..
[122] D. Crispim,et al. Role of Innate Immunity in Preeclampsia: A Systematic Review , 2017, Reproductive Sciences.
[123] C. Patriquin,et al. Thrombotic microangiopathies: a general approach to diagnosis and management , 2017, Canadian Medical Association Journal.
[124] I. López-Vílchez,et al. Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model , 2016, Translational psychiatry.
[125] J. Kochenderfer,et al. Toxicities of chimeric antigen receptor T cells: recognition and management. , 2016, Blood.
[126] S. Karumanchi. Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy. , 2016, Hypertension.
[127] N. Vaziri,et al. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[128] H. Baelde,et al. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[129] L. Magee,et al. Pre-eclampsia , 2016, The Lancet.
[130] F. Cunha,et al. Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis , 2016, PloS one.
[131] S. Brennecke,et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. , 2016, The New England journal of medicine.
[132] Adil Rafiq Rather,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .
[133] S. Hanash,et al. Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[134] K. Wilhelmsen,et al. Vascular endothelial cell Toll-like receptor pathways in sepsis , 2015, Innate immunity.
[135] H. Heslop,et al. Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs. , 2015, Blood.
[136] G. Espinosa,et al. ADAMTS-13 in Critically Ill Patients With Septic Syndromes and Noninfectious Systemic Inflammatory Response Syndrome , 2015, Shock.
[137] N. Rifai,et al. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease , 2015, PloS one.
[138] W. Kuebler,et al. Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation. , 2015, Comprehensive Physiology.
[139] M. Díaz-Ricart,et al. TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia , 2015, European journal of clinical investigation.
[140] T. Ikezoe. Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation , 2015, Journal of Intensive Care.
[141] J. Chudek,et al. Adipokines and endothelial dysfunction in acute myocardial infarction and the risk of recurrent cardiovascular events , 2015, Journal of cardiovascular medicine.
[142] M. Jacob,et al. Role of the glycocalyx in fluid management: Small things matter. , 2014, Best practice & research. Clinical anaesthesiology.
[143] C. Steyers,et al. Endothelial Dysfunction in Chronic Inflammatory Diseases , 2014, International journal of molecular sciences.
[144] I. López-Vílchez,et al. Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment. , 2014, Journal of affective disorders.
[145] I. Sargent,et al. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? , 2014, Placenta.
[146] Jing Zheng,et al. Regulation of Placental Angiogenesis , 2014, Microcirculation.
[147] Gautam Sethi,et al. The Vascular Endothelium and Human Diseases , 2013, International journal of biological sciences.
[148] R. Vanholder,et al. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. , 2013, Kidney international.
[149] M. Díaz-Ricart,et al. Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[150] P. Marsden,et al. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome , 2013, Virulence.
[151] V. Jha,et al. Chronic kidney disease: global dimension and perspectives , 2013, The Lancet.
[152] A. Teixeira-Carvalho,et al. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. , 2013, Cytokine.
[153] M. Díaz-Ricart,et al. NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach , 2012, PloS one.
[154] J. Carrero,et al. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[155] P. Legendre,et al. Von Willebrand Factor and ADAMTS13: A Candidate Couple for Preeclampsia Pathophysiology , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[156] J. Kaski,et al. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. , 2011, Atherosclerosis.
[157] R. Gomis,et al. Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses , 2011, Journal of thrombosis and haemostasis : JTH.
[158] J. Moake,et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. , 2011, The Journal of clinical investigation.
[159] M. Haubitz,et al. Circulating endothelial cells: markers and mediators of vascular damage. , 2010, Current stem cell research & therapy.
[160] L. Ngo,et al. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis , 2010, Critical care.
[161] R. Storb,et al. Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[162] D. James,et al. Intrinsic Depot-Specific Differences in the Secretome of Adipose Tissue, Preadipocytes, and Adipose Tissue–Derived Microvascular Endothelial Cells , 2010, Diabetes.
[163] D. Fliser,et al. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[164] M. Díaz-Ricart,et al. Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[165] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[166] B. Guidet,et al. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis , 2010, Intensive Care Medicine.
[167] A. Enomoto,et al. Indoxyl Sulfate Upregulates Expression of ICAM-1 and MCP-1 by Oxidative Stress-Induced NF-ĸB Activation , 2010, American Journal of Nephrology.
[168] Gökhan S Hotamisligil,et al. Endoplasmic reticulum stress and atherosclerosis , 2010, Nature Medicine.
[169] S. Bourdoulous,et al. Breaking the wall: targeting of the endothelium by pathogenic bacteria , 2010, Nature Reviews Microbiology.
[170] S. Rosenberg,et al. Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells , 2010, Journal of immunotherapy.
[171] I. López-Vílchez,et al. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. , 2009, Cardiovascular research.
[172] D. R. Faber,et al. Role of adipose tissue in haemostasis, coagulation and fibrinolysis , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[173] H. Hauner,et al. Functional analyses reveal the greater potency of preadipocytes compared with adipocytes as endothelial cell activator under normoxia, hypoxia, and TNFalpha exposure. , 2009, American journal of physiology. Endocrinology and metabolism.
[174] I. López-Vílchez,et al. Serotonergic mechanisms enhance platelet-mediated thrombogenicity , 2009, Thrombosis and Haemostasis.
[175] M. Díaz-Ricart,et al. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[176] Meijing Wang,et al. ANGIOPOIETIN-1 IN THE TREATMENT OF ISCHEMIA AND SEPSIS , 2009, Shock.
[177] A. Gratwohl,et al. Vascular endothelium as 'novel' target of graft-versus-host disease. , 2008, Best practice & research. Clinical haematology.
[178] M. Díaz-Ricart,et al. Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[179] Peter Stenvinkel,et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[180] W. Wiersinga,et al. Inflammation, endothelium, and coagulation in sepsis , 2008, Journal of leukocyte biology.
[181] Jordan S. Pober,et al. Evolving functions of endothelial cells in inflammation , 2007, Nature Reviews Immunology.
[182] E. Maury,et al. Adipokines oversecreted by omental adipose tissue in human obesity. , 2007, American journal of physiology. Endocrinology and metabolism.
[183] D. Vestweber. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium , 2007, Immunological reviews.
[184] J. Griffith,et al. The Framingham predictive instrument in chronic kidney disease. , 2007, Journal of the American College of Cardiology.
[185] G. Fantuzzi,et al. Adipose Tissue and Atherosclerosis: Exploring the Connection , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[186] M. Matsuda,et al. Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.
[187] M. Gawaz,et al. Platelets and endothelial cells. , 2007, Seminars in thrombosis and hemostasis.
[188] W. Aird. Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds , 2007, Circulation research.
[189] William C. Aird,et al. Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms , 2007, Circulation research.
[190] W. Aird,et al. Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. , 2007, Blood.
[191] A. Saltiel,et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.
[192] S. Rosenberg,et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells , 2005, The Journal of experimental medicine.
[193] W. Chaplin,et al. Role of depression and inflammation in incident coronary heart disease events. , 2005, The American journal of cardiology.
[194] M. Díaz-Ricart,et al. Uremic platelet dysfunction: past and present. , 2005, Current hematology reports.
[195] A. Sherwood,et al. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. , 2005, Journal of the American College of Cardiology.
[196] W. Aird,et al. Spatial and temporal dynamics of the endothelium , 2005, Journal of thrombosis and haemostasis : JTH.
[197] P. Scherer,et al. Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.
[198] E. Dejana,et al. Expression of junctional adhesion molecule-A prevents spontaneous and random motility , 2005, Journal of Cell Science.
[199] F. Roudot-thoraval,et al. N-Acetylcysteine Treatment Normalizes Serum Tumor Necrosis Factor-&agr; Level and Hinders the Progression of Cardiac Injury in Hypertensive Rats , 2004, Circulation.
[200] T. van der Poll,et al. Sepsis and Disseminated Intravascular Coagulation , 2003, Journal of Thrombosis and Thrombolysis.
[201] Leslie A. Smith,et al. Protective Effect of Chronic Vitamin C Treatment on Endothelial Function of Apolipoprotein E-Deficient Mouse Carotid Artery , 2003, Journal of Pharmacology and Experimental Therapeutics.
[202] M. Díaz-Ricart,et al. Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[203] Kristin S. Jensen,et al. Endothelium-dependent effects of statins. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[204] S. Kirchner,et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. , 2002, Blood.
[205] D. Granger,et al. Adhesion molecules and their role in vascular disease. , 2001, American journal of hypertension.
[206] James J. Walker,et al. Pre-eclampsia , 2000, The Lancet.
[207] F. Dignat-George,et al. Circulating endothelial cells in vascular disorders: new insights into an old concept , 2000, European journal of haematology.
[208] J. Gamble,et al. Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions , 2000, Circulation research.
[209] M. Landray,et al. Abnormalities of endothelial function in patients with predialysis renal failure , 2000, Heart.
[210] S. Israels,et al. Platelet dense granules: structure, function and implications for haemostasis. , 1999, Thrombosis research.
[211] G. Garcı́a-Cardeña,et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[212] J. Loscalzo,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.
[213] S. Burdach,et al. Endothelial dysfunction after bone marrow transplantation: Increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications , 1998, Annals of Hematology.
[214] A. Blann,et al. Vascular endothelial lesion in patients undergoing bone marrow transplantation. , 1996, Bone marrow transplantation.
[215] S. Tura,et al. Endothelium and bone marrow transplantation. , 1996, Bone marrow transplantation.
[216] M. Ueffing,et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. , 1995, Blood.
[217] H. Augustin,et al. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.
[218] H. Shulman,et al. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation. , 1992, Bone marrow transplantation.
[219] J. Armitage,et al. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. , 1991, Bone marrow transplantation.
[220] S. C. Guldris,et al. Gut microbiota in chronic kidney disease. , 2017, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[221] S. Rodríguez de Córdoba,et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. , 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[222] T. Ikezoe,et al. Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen , 2015, Bone Marrow Transplantation.
[223] Arthur S Slutsky,et al. Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .
[224] PhD Cuihua Zhang MD. The role of inflammatory cytokines in endothelial dysfunction , 2008, Basic Research in Cardiology.
[225] W. Aird. Endothelium in health and disease. , 2008, Pharmacological reports : PR.
[226] Douglas Losordo,et al. Statins and the endothelium. , 2007, Vascular pharmacology.
[227] John N Fain,et al. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. , 2006, Vitamins and hormones.
[228] M. Díaz-Ricart,et al. Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells. , 2002, Haematologica.
[229] M. Díaz-Ricart,et al. Uremic Medium Disturbs the Hemostatic Balance of Cultured Human Endothelial Cells , 2001, Thrombosis and Haemostasis.
[230] R. Marcus,et al. Changes in the natural anticoagulants following bone marrow transplantation. , 1990, Bone marrow transplantation.